Where completion mechanics and conditions in a cross-border SPA stands now

A share purchase agreement that looks clean in term-sheet form can unravel at completion when the transaction crosses a jurisdictional boundary. The vehicle sits in the BVI. The target operates in the Mainland. The buyer's counsel is in Hong Kong. Each system applies a different logic to what "completion" means, what conditions must be satisfied before title passes, and what happens when a condition fails or a representation proves false after the keys change hands. The commercial stakes are not abstract: a mis-sequenced completion can void the transfer, trigger regulatory penalties, or leave the buyer holding a shell without the underlying asset.

In a cross-border SPA governed by Hong Kong law and involving a Greater China asset or a BVI or Cayman holding vehicle, completion mechanics and conditions precedent are governed by the parties' agreement read in accordance with common-law principles, with three external constraints that the parties cannot contract out of: applicable foreign-investment approvals, Mainland regulatory clearances where a People's Republic of China target or business is involved, and the Companies Ordinance (Cap. 622) requirements attaching to any Hong Kong-incorporated entity in the chain.

This analysis examines what is actually at stake commercially, how the cross-border interface bites on the mechanics, where the comparative read sits between Hong Kong and the Mainland, and where our desk sees the risk concentrating in the current deal environment.

What is actually at stake: the commercial logic of the condition and the mechanic

Completion mechanics and conditions precedent in an SPA are not procedural boilerplate. They are the allocation of deal risk between signing and the transfer of title. Every day a condition remains unsatisfied, the deal can die – and in a cross-border transaction, the party with the better walk-away right is the party whose counsel drafted the conditions schedule with the applicable regulatory regime in mind.

The commercial question is sharper than it appears. In a purely domestic transaction, the parties can often agree a short gap between signing and completion, satisfy conditions within weeks, and close with a standard set of completion deliverables. In a cross-border SPA touching Greater China, that gap can extend to months. Foreign-investment approvals, merger-notification filings, and Mainland regulatory procedures each run on their own clock. A buyer who has not built that clock into the conditions and long-stop mechanics has, in practice, given the seller a free option to renegotiate the price if market conditions move.

Our desk regularly sees this structural error in transactions where the initial drafting was done without reference to the Mainland regulatory timetable. The conditions are expressed in generic terms – "receipt of all regulatory approvals" – without specifying the approving body, the form of approval, or the consequence of a partial or conditional grant. When the approval arrives qualified, the parties dispute whether the condition is satisfied. That dispute is itself a risk: a completion delayed while the parties argue about whether a condition is met is a deal exposed to third-party interference, market movement, and the other side's optionality.

The practical stakes also include the allocation of completion risk in the accounts and the price adjustment mechanism. A locked-box completion – where the economic interest transfers at a fixed date prior to completion – operates differently from a completion-accounts mechanism in a cross-border structure where the underlying business is in the Mainland and the accounts are prepared under PRC accounting standards. That interface between the economic-transfer date, the legal-title-transfer date, and the applicable accounting standard is a recurring source of post-completion dispute.

How does the governing framework apply in a cross-border SPA?

The governing framework for completion mechanics in a cross-border SPA is a composite: the parties' chosen governing law (typically English law or Hong Kong law for Greater China transactions), the lex situs of the shares being transferred, the regulatory regimes of the jurisdictions in which the target business operates, and – where a PRC entity is in the chain – the Mainland's foreign-investment and merger-control rules.

Hong Kong common law treats the conditions precedent in an SPA as contractual conditions, not merely procedural steps. If a condition is not satisfied or waived by the long-stop date, the agreement terminates by its own terms. The question of whether a condition has been satisfied is one of contractual interpretation, and Hong Kong courts apply an objective test. This matters because Mainland regulatory approvals are rarely binary: they arrive with schedules, attachments, and qualifications. A condition drafted as "receipt of approval from [body] in the form set out in Schedule [X]" is cleaner than a generic formulation, but it requires the drafting counsel to know what that approval will look like before signing.

The lex situs point is frequently underweighted. Where the shares being transferred are shares in a BVI or Cayman company, the formal transfer of legal title is governed by the law of the BVI or Cayman Islands respectively – typically execution and delivery of a share transfer instrument and registration in the register of members. The Companies Ordinance (Cap. 622) governs the mechanics for Hong Kong-incorporated entities in the chain, including any required filings at the Companies Registry. These steps are not conditions precedent; they are completion deliverables. But the sequence matters: regulatory approval is typically required before the share transfer instrument can be executed, and the share transfer must be completed before a new director can take office. A completion agenda that runs these steps in the wrong order can produce a period during which the buyer has paid but does not legally hold the shares.

The Mainland regulatory overlay is the third layer. Under the PRC's foreign-investment regime and its merger-notification rules, a transaction that meets the relevant thresholds requires notification and clearance before completion. The substantive rules and thresholds are not reproduced here, as the exact position depends on the sector, the transaction size, and the parties' footprints – all of which should be verified with the relevant advisers. What the SPA drafter needs to know is that the Mainland regulatory clock is not within the parties' control: the approval body's timetable runs independently of the contractual long-stop. A long-stop date set without reference to the actual filing and review period creates a condition that the parties cannot satisfy by effort alone.

Where does the cross-border interface actually bite?

The interface between Hong Kong law, BVI or Cayman holding-company mechanics, and Mainland regulatory requirements creates four specific pressure points in a cross-border SPA. Each is worth examining in turn.

The first is the condition-satisfaction standard. Hong Kong common law treats a condition precedent as satisfied when the substantive requirement is met, not merely when a document has been issued. A Mainland approval that grants the transaction but imposes a post-completion obligation – say, a requirement to maintain employment levels for a defined period – does not automatically fail the condition, but it does create a compliance obligation that the SPA should allocate. In our cross-border practice, we see transactions where this allocation is absent: the approval arrives, the condition is waived, the deal closes, and the post-completion obligation surfaces six months later as an unallocated liability.

The second pressure point is the material adverse change (MAC) clause – a clause that allows a party to refuse to complete if a defined adverse change occurs between signing and completion. In a cross-border SPA with a Mainland target, the MAC clause must be calibrated to the regulatory environment. A generic MAC definition that captures any change in "applicable law" will be triggered by routine Mainland regulatory adjustments that are not in fact adverse to the business. Conversely, a MAC clause that is too narrow will fail to capture a genuine deterioration in the regulatory position of the target.

The third pressure point is the long-stop date and its extension mechanics. A single long-stop date may be appropriate in a domestic transaction. In a cross-border deal with multiple parallel regulatory approvals, a tiered long-stop – with separate dates for each approval, a right of extension if a specified condition is pending, and a final long-stop that neither party can extend – is more reflective of the actual risk. The allocation of break fees where the deal fails at long-stop is a related point: a seller who has invested six months in a regulatory process has a different break-fee expectation than one whose condition was purely mechanical.

The fourth pressure point is the completion-accounts or locked-box mechanic and its interaction with the regulatory timetable. A locked-box structure fixes the economic risk at a date before completion; any value leakage between the locked-box date and completion is addressed through the leakage regime. But in a cross-border deal, the locked-box date may precede the regulatory approval by several months. During that period, the underlying business is being managed for the seller's account. The leakage definition must be calibrated to capture not only obvious cash extraction but also decisions that affect the Mainland entity's regulatory position in a way that alters the value of what the buyer is acquiring.

A mid-market acquisition of a manufacturing group with a BVI holding structure and Mainland operating entities illustrates the point. The SPA was signed with a three-month long-stop and a generic approval condition. The Mainland regulatory filing was not made until after signing, because the parties had not agreed on the filing strategy before execution. The filing generated a supplementary information request, extending the review period. The long-stop arrived before clearance; the seller exercised a termination right. The deal was ultimately restructured, but only after a six-month delay and a material renegotiation of price. The error was in the condition-drafting, not in the underlying transaction logic.

The comparative read: Hong Kong and the Mainland as co-principals

The comparative question in a cross-border SPA is not which system "governs" the transaction – that is determined by the governing-law clause. The question is how the two systems interact, and which system's requirements constrain the parties' freedom to complete.

Hong Kong common law is highly permissive of party autonomy in commercial contracts. Subject to the regulatory overlays noted above, parties can agree any completion mechanics they choose: simultaneous exchange and completion, a gap between exchange and completion, a phased completion, or a deferred completion linked to performance milestones. The courts will enforce the agreed mechanics as drafted, without importing implied terms that modify the express allocation of risk. This is why the drafting of conditions in a Hong Kong-law SPA carries greater legal weight than in some civil-law systems, where mandatory statutory provisions may supplement or override the parties' agreement.

The Mainland position is structurally different. In a transaction involving a PRC entity – whether a wholly foreign-owned enterprise, a joint venture, or a variable interest entity – the completion of the share transfer requires registration with the relevant market-supervision authority. Legal title to the equity interest in a Mainland entity does not pass on execution of a share transfer instrument; it passes on registration. This is not a technicality. A buyer who has paid but whose name does not yet appear in the registered equity record does not hold the asset in a legally enforceable sense under Mainland law. The SPA must reflect this: the completion deliverable should include confirmation of the registration update, not merely execution of the transfer documents.

The interaction between Hong Kong common law and the Mainland registration requirement creates a sequencing challenge. Under Hong Kong law, the condition is satisfied when the approval is granted. Under Mainland practice, the practical effect of the transfer is not complete until registration is updated, which may occur days or weeks after the approval. If the SPA defines completion as execution of the share transfer instrument following receipt of approval, the buyer may close before the registration is updated – and in the interim, hold a contractual right to the asset but not the legal title. Our desk structures the completion mechanics to capture this gap explicitly, typically by making the registration update a completion deliverable rather than a post-completion obligation.

The BVI and Cayman layer adds a third system. In a structure where a BVI or Cayman holdco sits above the Mainland opco, the legal transfer of the BVI or Cayman shares is a matter of BVI or Cayman law and is completed on execution of the share transfer form and updating of the register of members. This transfer is legally effective regardless of the Mainland registration status of the underlying opco equity. In practice, this means the buyer can be the legal owner of the BVI holdco before the Mainland registration is updated – creating a window in which the BVI title is clean but the practical control of the underlying asset is in question. The completion agenda should close this window, not leave it open.

For details on how these structural considerations interact with the choice of acquisition vehicle and its tax implications, see our analysis at M&A & Transactions.

Conditions precedent in practice: drafting for the regulatory environment

The drafting of conditions precedent in a cross-border SPA is, in effect, a regulatory-mapping exercise. The drafter needs to know, before signing, which regulatory approvals are required, which body grants them, in what form they are issued, and what the realistic timetable is. That knowledge drives the drafting of the condition, the long-stop date, the break-fee structure, and the obligations of each party to cooperate in satisfying the conditions.

The standard approach in our cross-border practice is to identify each required approval by reference to the specific regulatory regime, name the approving body generically but precisely, define the form of satisfactory approval with sufficient specificity to exclude a conditional grant that imposes unacceptable ongoing obligations, and set a long-stop date that builds in a realistic period for the full regulatory cycle – including the possibility of a supplementary information request.

The obligations of the parties to pursue satisfaction of the conditions is a frequently contested point. A buyer obligated to use "reasonable endeavours" to obtain a regulatory approval is in a different position from one obligated to use "best endeavours." The distinction matters in Hong Kong common law: "best endeavours" requires the obligated party to take all steps within its power, including steps that are commercially disadvantageous, whereas "reasonable endeavours" requires only those steps that a reasonable commercial party would take. In a cross-border deal where the regulatory approval requires the buyer to make representations about its ultimate beneficial ownership, a best-endeavours obligation may require the buyer to disclose information it would prefer to withhold.

The warranty-and-condition interface is a related drafting point. In a cross-border SPA, the buyer typically obtains warranties about the target's regulatory compliance as at signing and as at completion – so-called bring-down warranties. The interaction between a bring-down warranty and a MAC condition needs careful drafting: if a regulatory development between signing and completion is simultaneously a breach of warranty and a MAC event, the buyer should not be in a position where it must elect one remedy to the exclusion of the other. The SPA should preserve both.

For further analysis of how the warranty and indemnity package interacts with the conditions and completion mechanics in an Asia deal, see our guide at warranties and indemnities in Asia deal structures.

The sequence above describes the standard position. Your matter turns on the documents, the jurisdictions actually engaged, and the order of steps – which is where the route is won or lost. For a structured assessment of your completion mechanics and conditions across the relevant jurisdictions, write to us at info@lockhartyip.com.

What do foreign principals get wrong in a cross-border SPA?

In our experience advising on cross-border transactions in the Greater China region, four errors recur in SPA completions drafted without adequate attention to the multi-system interface.

The first is treating the Mainland regulatory timetable as a variable the parties can control. They cannot. The filing strategy, the form of the filing, and the pre-submission engagement with the relevant authority can all affect the duration of the review – but the authority's internal timetable is not subject to contractual control. Buyers who have set aggressive long-stop dates on the assumption that the regulatory clock can be managed have, in our observation, consistently been exposed to seller optionality at long-stop.

The second error is failing to address the gap between the BVI or Cayman title transfer and the Mainland registration update. This gap is structural, not accidental. It is a feature of the holding-company model that the legal transfer of the holdco shares is instantaneous – execution and registration update can occur on the same day – while the Mainland registration update follows its own timetable. A completion agenda that does not address this gap explicitly leaves the buyer in a position of legal ownership of the holdco without practical control of the underlying asset.

The third error is the use of generic MAC definitions. A MAC clause calibrated to a domestic UK or US transaction will capture regulatory developments in the Mainland that are routine and expected, and will fail to capture developments that are genuinely adverse. The result is a clause that neither party understands clearly, and that will be litigated if a relevant event occurs.

The fourth error – and perhaps the most commercially significant – is the failure to address the interaction between the completion-accounts or locked-box mechanic and the regulatory timetable. In a deal where the economic transfer date precedes the regulatory approval by several months, the leakage and locked-box regime must be carefully calibrated to the actual risk of value extraction in a Mainland operating entity during a regulatory review period.

If an earlier filing, structure or completion attempt produced an adverse or stalled result, a second read can identify the strategic error and the routes still open. Write to us at info@lockhartyip.com to discuss.

Where the risk sits now: our analytical read

The current deal environment in Greater China presents a specific configuration of risks for cross-border SPA completions. Three developments shape the position as at the date of this analysis.

The first is the evolving foreign-investment scrutiny applied to transactions involving certain sectors and asset types in the Mainland. The direction of travel in the regulatory environment has been toward greater review of inbound and outbound transactions in sensitive sectors. That trend does not affect all transactions, and it is not a reason to avoid cross-border M&A in Greater China. It is, however, a reason to build more time and more specificity into the conditions precedent and the long-stop mechanics than was standard practice in earlier periods.

The second is the maturation of the reciprocal enforcement environment between Hong Kong and the Mainland. The Mainland Judgments in Civil and Commercial Matters (Reciprocal Enforcement) Ordinance (Cap. 645), which came into force on 29 January 2024, has expanded the scope of Hong Kong-court judgments that can be enforced directly in the Mainland and vice versa. For an SPA governed by Hong Kong law with a dispute-resolution clause selecting the Hong Kong courts, this development has strengthened the enforceability of contractual completion obligations against a Mainland counterparty. A buyer seeking to enforce a completion obligation – or to resist a termination purported to be lawful – now has a clearer enforcement route than existed under the earlier regime. This does not replace arbitration as the preferred dispute-resolution mechanism for cross-border SPAs, but it changes the calculus for parties who preferred court-based resolution.

The third is the increasing prevalence of warranty and indemnity insurance in Asian deals. This product – W&I insurance (a policy that transfers the buyer's warranty claims risk from the seller to a third-party insurer) – has reshaped the commercial dynamics of SPA negotiations in the region. In a cross-border SPA, the availability of W&I cover for Mainland-related warranties is now a routine diligence question. Where cover is available, sellers are more willing to provide clean-title warranties backed by insurance rather than escrow; where it is not, the completion mechanics and retention arrangements need to reflect the residual risk. The conditions precedent should reflect which warranties are insured and which are carried by the seller or the buyer on the balance sheet.

Taken together, these three developments point toward a deal environment in which the procedural mechanics of a cross-border SPA matter more, not less. The regulatory timetable is longer and less predictable in sensitive sectors. The enforcement route for contractual obligations is clearer and more usable. The risk-transfer architecture of the warranty package has become more sophisticated. Counsel who approaches the conditions and completion mechanics as boilerplate is operating with an outdated understanding of where the risk sits.

For considerations on the specific acquisition vehicle and how that choice interacts with completion mechanics, see our briefing at acquiring a Hong Kong target through a BVI buyer.

Decision map: matching the deal structure to the completion mechanic

The following map describes, in prose, the principal situations our desk encounters and the completion-mechanic approach each calls for. It is not exhaustive, and no situation maps precisely onto a template.

Situation A – buyer is a foreign entity acquiring a BVI holdco above a Mainland opco, no PRC regulatory approval required: The completion mechanic can be structured as simultaneous exchange and completion, with the core deliverable being execution of the BVI share transfer instrument and an update of the register of members on closing day. The conditions precedent are typically limited to board approvals, antitrust clearances (if applicable), and third-party consents under material contracts. The Mainland registration update is a post-completion obligation, allocated by covenant. Risk concentration: the gap between BVI title transfer and Mainland registration; managed by a completion covenant with a defined timetable and a mechanism for the parties to cooperate on the update.

Situation B – buyer is acquiring a PRC entity directly (equity interest transfer), Mainland regulatory approval required: Completion cannot occur until the Mainland regulatory approval is obtained and the equity registration is updated. The conditions precedent must include the regulatory approval in a form satisfactory to the buyer, defined with reference to the specific approving body and the acceptable conditions of the grant. The long-stop date should reflect the realistic regulatory timetable, with a built-in extension right if the filing is pending. Risk concentration: the regulatory timetable; the definition of satisfactory approval; and the MAC clause calibration.

Situation C – acquisition of a Hong Kong-incorporated company, no Mainland assets: The completion mechanic follows the Companies Ordinance (Cap. 622) requirements for the transfer of shares in a Hong Kong company, including any stamp-duty obligations and the filing of the necessary returns at the Companies Registry. The ad valorem stamp duty on the transfer of Hong Kong stock is 0.1% per party (0.2% in total) on the higher of consideration or market value. Conditions precedent are typically limited to standard regulatory clearances and board approvals. Risk concentration: the stamp-duty mechanics and the timing of Companies Registry filings.

Situation D – phased acquisition with deferred completion or completion by instalments: The conditions precedent must address each phase separately. A condition satisfied for the first tranche may not be satisfied for the second if the regulatory environment changes between tranches. The MAC clause must be calibrated to operate at the phase level, not merely at the transaction level. Risk concentration: the interaction between the phased completion mechanism and the MAC clause; the allocation of leakage risk between phases.

The objection: can the parties simply agree their own mechanics and ignore the regulatory layer?

A recurring objection from principals who have transacted in less regulated environments is that the parties can agree any mechanics they choose and treat the regulatory requirements as a back-office matter. This is the prevalent myth our desk encounters in Greater China transactions.

The short answer is no. Party autonomy in a Hong Kong-law SPA is broad, but it operates within the regulatory perimeter set by the applicable foreign-investment regime, the merger-notification rules, and – where a Mainland entity is in the chain – the Mainland's mandatory registration requirements. Completion mechanics that purport to transfer legal title ahead of the required regulatory approval do not simply create a contractual risk: they may render the transfer void or unenforceable under the applicable regulatory regime, expose the parties to administrative penalties, and in certain sectors create a situation where the transfer itself triggers a regulatory review that would not otherwise have applied.

The assumption that a BVI or Cayman holdco structure insulates the parties from Mainland regulatory requirements is also a common misconception. The lookthrough approach applied by Mainland regulatory authorities in assessing whether a transaction involves a Mainland asset or business means that a change of control at the holdco level can trigger Mainland regulatory requirements even if no Mainland entity is itself being transferred. The conditions precedent in a cross-border SPA must be drafted with this lookthrough approach in mind.

Related practices

• Holding Structures – structuring the acquisition vehicle above Hong Kong and Mainland operating entities
• Tax Positions – territorial basis, FSIE regime, and cross-border structuring for deal completions

Speak with Lockhart & Yip

For a scoped view of your matter, contact info@lockhartyip.com. Discuss your matter →

Related

• Ma Transactions
• Warranties Indemnities Wandi Insurance Asia Deal Guide
• Acquiring Hong Kong Target Bvi Buyer Bvi Briefing

This publication is general information and does not constitute legal advice. For advice on your situation, contact info@lockhartyip.com.